Carmustine and Brain oedema - a phase IV clinical study of FDA data

Summary:

Brain oedema is reported as a side effect among people who take Carmustine (carmustine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Decadron, and have Glioblastoma multiforme.

The phase IV clinical study analyzes which people have Brain oedema when taking Carmustine. It is created by eHealthMe based on reports of 4,562 people who have side effects when taking Carmustine from the FDA, and is updated regularly.

What is Carmustine?

Carmustine has active ingredients of carmustine. eHealthMe is studying from 4,562 Carmustine users. Check the latest studies of Carmustine.

What is Brain oedema?

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain) is found to be associated with 966 drugs and 1,252 conditions by eHealthMe. Check the latest studies of Brain oedema.

On Jul, 11, 2026

4,562 people reported to have side effects when taking Carmustine.
Among them, 34 people (0.75%) have Brain oedema.

Among these 34 people:

How long have people been on Carmustine when they have Brain oedema? *

What is the gender of people who have Brain oedema when taking Carmustine? *

female: 52 %
male: 48 %

What is the age of people who have Brain oedema when taking Carmustine? *

What are other drugs people take besides Carmustine? *

What are other side effects people have besides Brain oedema? *

Weakness: 9 people, 26.47%
General Physical Health Deterioration (weak health status): 9 people, 26.47%
Fatigue (feeling of tiredness): 9 people, 26.47%
Death: 8 people, 23.53%
Decreased Interest: 8 people, 23.53%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 8 people, 23.53%
Depressed Level Of Consciousness: 8 people, 23.53%
Eye Movement Disorder: 8 people, 23.53%
Fall: 8 people, 23.53%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 8 people, 23.53%

What are the existing conditions these people have? *

Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 8 people, 23.53%
Malignant Glioma (cancerous tumour of brain a cancer tumour of uncertain origin that arises both in soft tissue and bone): 5 people, 14.71%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 11.76%
Glioma (a type of tumour that starts in the brain or spine): 3 people, 8.82%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 2.94%
Pseudomeningocele (abnormal collection of cerebrospinal fluid): 1 person, 2.94%
Pain: 1 person, 2.94%
Multiple Myeloma (cancer of the plasma cells): 1 person, 2.94%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 1 person, 2.94%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Carmustine and have Brain oedema?

- Check whether Brain oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carmustine:

Carmustine (4,562 reports)

Brain oedema treatments and more:

Brain oedema (16,340 reports)

Browse all side effects of Carmustine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Brain oedema:

Brain oedema (966 drugs)

Browse all the conditions that are associated with Brain oedema:

Brain oedema (1,252 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on carmustine (the active ingredients of Carmustine) and Carmustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.